Andrew Bruce

Andrew Bruce is a biopharmaceutical industry executive specializing in access and reimbursement policy and government affairs, with over 20 years of health policy experience on national, regional, and global levels. Currently serving as the Executive Director of Global Access Policy and Public Affairs at BioNTech SE, Andrew has previously held leadership roles at organizations such as Amgen and Medicines Australia, successfully managing complex negotiations with policymakers and advancing health policies in the industry. Andrew holds a Bachelor of Arts (Honours) with First Class Honours from the University of Sydney.